Ultrasonography in the polycystic ovarian syndrome

update

Authors

  • Wellington de Paula Martins Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Escola de Ultrassonografia e Reciclagem Médica Ribeirão Preto (EURP)
  • Patricia Spara Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Escola de Ultrassonografia e Reciclagem Médica Ribeirão Preto (EURP); Universidade Federal de Campina Grande (UFCG)
  • Francisco Mauad Filho Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Escola de Ultrassonografia e Reciclagem Médica Ribeirão Preto (EURP)
  • Antonio Gadelha Costa Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Escola de Ultrassonografia e Reciclagem Médica Ribeirão Preto (EURP); Universidade Federal de Campina Grande (UFCG)
  • Oscar Alves Escola de Ultrassonografia e Reciclagem Médica Ribeirão Preto (EURP)
  • Orozimbo S Carvalho Filho Universidade Federal de Campina Grande (UFCG)

Keywords:

ultrasound, polycystic ovary syndrome, anovulation

Abstract

European Society for Human Reproduction and the American Society of Reproductive Medicine in 2003 suggested that polycystic ovary syndrome is diagnosed when two of the following criteria are recognized: oligomenorrhea and/or anovulation, clinical or biochemical signs of hyperandrogenism, ultrasound findings of polycystic ovary. This review intends to show the importance of ultrasound in polycystic ovary syndrome diagnostic.

References

Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29:181–191.

Stein IF. Duration of infertility following ovarian wedge resection. West J Surg 964; 72:237–241.

Goldzieher JW, Axelrod LR. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 1963; 14:631–53.

McArthur JW, Igersoll FM, Worcester J.The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol Metab. 1958; 18:1202-15.

Yen SS, Vela P, Rankin J. Inappropriate secretion of follicle stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 1970; 30:435–42.

Givens JR, Andersen RN, Wiser WL et al. Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. J Clin Endocrinol Metab 1974; 38:727–35.

Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 1976; 57:1320-9.

Kahn CR, Flier JS, Bar RS et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 1976; 294:739–45.

Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.J Clin Endocrinol Metab 1980; 50:113–6.

Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983; 57:356-9.

Swanson M, Sauerbrei EE, Cooperberg PL. Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultrasound 1981; 9:219–22.

Adams J, Franks S, Polson DW et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin-releasing hormone. Lancet 1985; 2:1375–9.

Polson DW, Adams J, Wadsworth J, Franks S, et al. Polycystic ovaries a common finding in normal women.Lancet. 1988; 1:870-2.

Downloads

Published

2009-03-01

How to Cite

1.
Martins W de P, Spara P, Mauad Filho F, Costa AG, Alves O, Carvalho Filho OS. Ultrasonography in the polycystic ovarian syndrome: update. RBUS [Internet]. 2009 Mar. 1 [cited 2025 Jan. 18];9(10):40-2. Available from: https://revistarbus.sbus.org.br/rbus/article/view/19

Issue

Vol. 9 No. 10 (2009): Revista Brasileira de Ultrassonografia

Section

Review Articles